These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 12107743)

  • 21. Fibrinolytic measurements in type 2 diabetic patients with acute cerebral infarction.
    Mansfield MW; Catto AJ; Carter AM; Grant PJ
    Diabet Med; 1998 Nov; 15(11):953-7. PubMed ID: 9827850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Characteristics of dysfunction of islet beta-cell in newly diagnosed type 2 diabetic patients].
    Li YB; Zhu DL; Tian HM; Shi LX; Luo ZJ; Yan L; Zeng LY; Zhou ZG; Yang LY; Liu J; Li M; Weng JP
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(36):2537-41. PubMed ID: 17198561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased level of von Willebrand factor is significantly and independently associated with diabetes in postinfarction patients. THROMBO Investigators.
    Zareba W; Pancio G; Moss AJ; Kalaria VG; Marder VJ; Weiss HJ; Watelet LF; Sparks CE
    Thromb Haemost; 2001 Sep; 86(3):791-9. PubMed ID: 11583309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetic neuropathy is associated with activation of the TNF-alpha system in subjects with type 1 diabetes mellitus.
    González-Clemente JM; Mauricio D; Richart C; Broch M; Caixàs A; Megia A; Giménez-Palop O; Simón I; Martínez-Riquelme A; Giménez-Pérez G; Vendrell J
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):525-9. PubMed ID: 16268804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasminogen activator inhibitor-1 and tissue-plasminogen activator in minority adolescents with type 2 diabetes and obesity.
    Umpaichitra V; Hussain MM; Castells S
    Pediatr Res; 2005 Sep; 58(3):483-7. PubMed ID: 15901895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucagon as a determinant of fibrinolytic activity in men with different stages of glucose tolerance: impact of glucagon on fibrinolysis.
    Henkel E; Gallo S; Siegert G; Koehler C; Hanefeld M
    Blood Coagul Fibrinolysis; 2007 Jun; 18(4):327-34. PubMed ID: 17473573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low serum PYY is linked to insulin resistance in first-degree relatives of subjects with type 2 diabetes.
    Boey D; Heilbronn L; Sainsbury A; Laybutt R; Kriketos A; Herzog H; Campbell LV
    Neuropeptides; 2006 Oct; 40(5):317-24. PubMed ID: 17045646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetes.
    Festa A; Williams K; Tracy RP; Wagenknecht LE; Haffner SM
    Circulation; 2006 Apr; 113(14):1753-9. PubMed ID: 16585388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure.
    Suskin N; McKelvie RS; Burns RJ; Latini R; Pericak D; Probstfield J; Rouleau JL; Sigouin C; Solymoss CB; Tsuyuki R; White M; Yusuf S
    Eur Heart J; 2000 Aug; 21(16):1368-75. PubMed ID: 10952826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: is cellular insulin resistance caused by glucotoxicity in vivo?
    Burén J; Lindmark S; Renström F; Eriksson JW
    Metabolism; 2003 Feb; 52(2):239-45. PubMed ID: 12601640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Reduced resistin levels in patients with type 2 diabetes mellitus].
    Yang J; Li M; Wu CY; Wang H; Xu QS; Deng JY
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1471-4. PubMed ID: 14521723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
    da Silva RC; Miranda WL; Chacra AR; Dib SA
    J Diabetes Complications; 2007; 21(2):84-92. PubMed ID: 17331856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute effects of valsartan on insulin sensitivity in obese, non-hypertensive subjects with and without type 2 diabetes.
    Luzio SD; Dunseath G; Owens DR
    Horm Metab Res; 2002 May; 34(5):271-4. PubMed ID: 12063642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood coagulation and fibrinolysis in obese NIDDM patients.
    Avellone G; Di Garbo V; Cordova R; Rotolo G; Abruzzese G; Raneli G; De Simone R; Bompiani GD
    Diabetes Res; 1994; 25(2):85-92. PubMed ID: 7648783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of diminished beta cell reserve and insulin resistance in secondary sulfonylurea failure of type 2 diabetes mellitus.
    Rattarasarn C; Thamprasit A; Leelawattana R; Soonthornpun S; Setasuban W
    J Med Assoc Thai; 2001 Dec; 84(12):1754-62. PubMed ID: 11999824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of insulin treatment on the balance between tissue plasminogen activator and plasminogen activator inhibitor-1 in type 2 diabetic patients.
    Vukovich T; Proidl S; Knöbl P; Teufelsbauer H; Schnack C; Schernthaner G
    Thromb Haemost; 1992 Sep; 68(3):253-6. PubMed ID: 1440487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of plasminogen activator inhibitor-1 gene 4G/5G polymorphism on glucose and lipid metabolisms in Turkish obese children.
    Kinik ST; Ataç FB; Verdi H; Cetintaş S; Sahin FI; Ozbek N
    Clin Endocrinol (Oxf); 2005 May; 62(5):607-10. PubMed ID: 15853833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
    Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An increase in insulin sensitivity and basal beta-cell function in diabetic subjects treated with pioglitazone in a placebo-controlled randomized study.
    Wallace TM; Levy JC; Matthews DR
    Diabet Med; 2004 Jun; 21(6):568-76. PubMed ID: 15154941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship of glucose concentrations with PAI-1 and t-PA in subjects with normal glucose tolerance.
    Heldgaard PE; Sidelmann JJ; Hindsberger C; Olivarius Nde F; Henriksen JE; Gram J
    Diabet Med; 2006 Aug; 23(8):887-93. PubMed ID: 16911627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.